AQR Arbitrage’s Aerie Pharmaceuticals AERI Stock Holding History

AQR Arbitrage’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,078,446	Closed	-$16.3M	–	1483
2022 Q3	$16.3M	Buy	+1,078,446	New	+$12.5M	0.36%	59

AQR Arbitrage's AERI Position: Q4 2022 in Review

AQR Arbitrage sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 1,078,446 shares — an estimated $16.3M sold.

AQR Arbitrage first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $16.3M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

AQR Arbitrage reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
AQR Arbitrage sold 1,078,446 Aerie Pharmaceuticals shares in Q4 2022, an estimated $16.3M.
AQR Arbitrage first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
AQR Arbitrage's Aerie Pharmaceuticals position peaked at $16.3M in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on AQR Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.